公司資料
Cidara Therapeutics 股價、新聞與催化劑
- 股票代碼:
- CDTX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for CDTX.
公司概覽
業務概覽
Cidara Therapeutics is an anti-infective and immunotherapy company focused on drug-conjugate and engineered-therapy approaches. Its platform is aimed at serious infectious disease and immune-mediated conditions.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Cidara sits in specialty biotechnology.
商業模式特徵
The business depends on clinical data, platform validation, and the ability to create a differentiated anti-infective franchise.
生技產業定位
Cidara is a catalyst-sensitive anti-infective name with meaningful dependence on program progress.
未來催化劑
- Cidara’s catalysts are CD388 and the broader antiviral/immunology platform, where the market will watch for development steps that show the lead asset can keep advancing. The company still needs clinical validation to keep the thesis strong.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。